JAKARTA – Indonesia plants to boost output of vaccines by nearly 18% to 2 billion doses in 2014 with state-owned Bio Farma looking to build capacity with new technology ahead of the launch of universal health care insurance and to increase exports under its World Health Organization prequalified status.
Indonesia’s vaccine program benefits from a large population and the ability to export to keep production facilities running steadily; there...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?